BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37752476)

  • 1. Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: a multicenter retrospective 10-year analysis.
    Shan M; Deng Y; Zou W; Fan S; Li Y; Liu X; Wang J
    BMC Cancer; 2023 Sep; 23(1):905. PubMed ID: 37752476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
    Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
    Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
    Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
    Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
    Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
    [No Abstract]   [Full Text] [Related]  

  • 5. Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer.
    Kim SW; Chun M; Ryu HS; Chang SJ; Kong TW; Lee EJ; Lee YH; Oh YT
    Strahlenther Onkol; 2017 Jul; 193(7):534-542. PubMed ID: 28357468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer.
    Kim HJ; Chang JS; Koom WS; Lee KC; Kim GE; Kim YB
    Gynecol Oncol; 2018 Nov; 151(2):208-214. PubMed ID: 30195468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
    Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
    [No Abstract]   [Full Text] [Related]  

  • 9. Propensity score-matched analysis of systemic chemotherapy versus salvage hysterectomy for persistent cervical cancer after definitive radiotherapy/concurrent chemoradiotherapy.
    Takekuma M; Takahashi F; Mabuchi S; Kudaka W; Horie K; Ikeda M; Shikama A; Mitsuhashi A; Nagao S; Suzuki S; Mizuno M; Nishio S; Tokunaga H; Ota Y; Kasamatsu T; Kitagawa R; Toita T; Kobayashi H; Ishikawa M; Yaegashi N
    BMC Cancer; 2020 Nov; 20(1):1169. PubMed ID: 33256667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer.
    Chai Y; Wang T; Wang J; Yang Y; Gao Y; Gao J; Gao S; Wang Y; Zhou X; Liu Z
    BMC Cancer; 2014 Feb; 14():63. PubMed ID: 24495453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
    Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ
    Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
    Ni W; Yang J; Deng W; Xiao Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Zhang T; Bi N; Deng L; Wang W
    BMC Cancer; 2020 Feb; 20(1):144. PubMed ID: 32087687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Wei Z; Zhang Z; Luo J; Li N; Peng X
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
    Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
    BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience of pelvic radiotherapy or chemoradiotherapy for postoperative uterine cervical cancer using intensity-modulated radiation therapy.
    Yamamoto T; Umezawa R; Tokunaga H; Kubozono M; Kozumi M; Takahashi N; Matsushita H; Kadoya N; Ito K; Sato K; Tsuji K; Shimada M; Jingu K
    J Radiat Res; 2020 May; 61(3):470-478. PubMed ID: 32100833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal management of recurrent and metastatic upper tract urothelial carcinoma: Implications of intensity modulated radiation therapy.
    Kim MS; Koom WS; Cho JH; Kim SY; Lee IJ
    Radiat Oncol; 2022 Mar; 17(1):51. PubMed ID: 35264197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.
    Mabuchi S; Okazawa M; Matsuo K; Kawano M; Suzuki O; Miyatake T; Enomoto T; Kamiura S; Ogawa K; Kimura T
    Gynecol Oncol; 2012 Oct; 127(1):114-20. PubMed ID: 22728518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Radiotherapy Combined With Chemotherapy on Long-Term Outcomes of Patients With Recurrent Nasopharyngeal Carcinoma.
    Li Y; Liu W; Xu Y; Guo LY; Weng YL; Huang ZW; Chen XC; Lin T; Lu J; Qiu SF
    Technol Cancer Res Treat; 2023; 22():15330338231155721. PubMed ID: 36762400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.